Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. MONC:IM
2. PSKY
3. MONRY
4. PTON
5. NYXH
6. TDY
7. PNR
8. ACN
9. ONON
10. IAUX

Go back to Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.53 --0 (-0%)
Previous Close $2.53    52 Week High $4.76 
Open $2.53    52 Week Low $1.46 
Day High $2.53    P/E N/A 
Day Low $2.53    EPS $-1.91 
Volume 1,762